Search

Access to and uptake of cochlear implants in the UK

Assessing demands on cochlear implant (CI) services is very important for both commissioners and clinicians in anticipating clinical need and funding requirements. Commercial CI’s were introduced in the late 1980s. Initial funding was from charitable sources. The first major advance...

Aided cortical assessment: uses in a paediatric hearing implant centre

When can an aided cortical assessment help decision making in a child’s hearing journey? In this article, the author demonstrates the application using an enlightening case study approach. A device, be it a conventional hearing aid or hearing implant, ideally,...

Funding your otolaryngology / audiology idea by partnering with 
the US Department of Defense

The United States Department of Defense (DoD) has been an effective partner in many of our current medical technology advancements, from the surgical robot, to improved clotting wound dressings, to better blood products. For the otolaryngology and audiology entrepreneur looking...

A brief history of the acoustic ear trumpet and some collection favourites

If you think you know a thing or two about ear trumpets, I’d bet Michael Briggs knows more! In this fascinating article, he tells the history of the ear trumpet, as well as sharing some wonderful pictures from his Guiness...

Evidence based practice in paediatric audiology

Audiology, like most of the health sciences professions, has been working on integrating evidence-based practice principles since the mid-1990s [1]. Professional organisations and regulatory colleges have produced evidence-based clinical practice guidelines, disseminated them to audiologists and collaborated with practitioners to...

Intratympanic steroids in Ménière's disease: what’s the evidence?

The days of drastic surgery for Ménière's disease are long gone. We know that intratympanic injections can deliver high doses of medication to the inner ear with minimal discomfort and minimal risk. But how do we choose from the myriad...

Harnessing head and neck cancer genomics for personalised medicine

Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...